Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Lev Facher joins us to explain how the latest twist in Congress could imperil a bipartisan push to lower drug costs. Then, Baylor medical ethicist Stephanie Morain stops by to explain why a new crop of apps to match cancer patients with clinical trials comes with some serious concerns. Finally, STAT’s Casey Ross dials in to talk about how the giants of tech are making inroads in health and medicine.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].